REPLIGEN CORP - COMMON STOCK (RGEN)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
54,411,443
Share change
+290,159
Total reported value
$7,704,060,307
Put/Call ratio
87%
Price per share
$141.46
Number of holders
437
Value change
+$8,980,139
Number of buys
218
Number of sells
211

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q2 2023

As of 30 Jun 2023, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 437 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,411,443 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, BROWN CAPITAL MANAGEMENT LLC, Artisan Partners Limited Partnership, WELLINGTON MANAGEMENT GROUP LLP, and AMERIPRISE FINANCIAL INC. This page lists 441 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.